I find it hard to believe that failure will occur after today's...

First 17 Last

Share
Profile

Follow
IronMike94

617 Posts.

115

13/09/21

14:51

Post #: 56023063
Share

Originally posted by dunnomuch: ↑

$9 was my pie in the sky figure based on everything aligning to perfection but my base case, and what I have been thinking is a realistic level, was $1.41. At $1.41/share we are still just shy of a $250m market cap which I think is a real possibility if Sheba or RHC completes successfully. Mednax is just such a vast sized potential outcome that I try not to consider it in any estimations.

There are still more than 2 other European countries/hospital groups in discussions with HMD, Spain has just had a sign up, Brazil is still kicking along, RHC and Sheba are well advanced as is Mayo. Whenever I mention Mayo to other medtech companies it is greeted with almost disbelief, like finding out that Shane Warne is the new bowling coach for the U/16s at the local cricket club. The names involved are ALL massive in health and are all in trials. It is mind blowing just how close we are to something either extraordinary in success or failure. We are at the tipping point.

Expand

I find it hard to believe that failure will occur after today's update and the expansion of the trial in Sheba.

The tech has been validated through trials. These pilots were just to see how practical the adoption is with practitioners and patients and so far it looks like they've kicked it out the park.

I would be surprised if a commercial agreement isn't struck in the next 6 months. However, I am new in investing in this space so am hesitant to pour too much into this one. Also, have another stock that I believe is a no brainer which I have a majority of my funds tied into.

HMD Price at posting: 19.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply